TNFα promotes proliferation of oligodendrocyte progenitors and remyelination

Nature Neuroscience

Volumn 4, Issue 11, 2001, Pages 1116-1122

  Arnett, Heather A ^a,b   Mason, Jeff ^b,d   Marino, Mike ^c   Suzuki, Kinuko ^a,b   Matsushima, Glenn K ^a,b   Ting, Jenny P Y ^a,b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^d Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BROXURIDINE; CUPRIZONE; MYELIN PROTEIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELL PROLIFERATION; CELL STRAIN; CONTROLLED STUDY; DEMYELINATION; DISEASE DURATION; DRUG DESIGN; ELECTRON MICROSCOPY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MALE; MORPHOMETRICS; MOUSE; NERVE FIBER REGENERATION; NONHUMAN; OLIGODENDROGLIA; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DEFICIENCY; REGULATORY MECHANISM; REMYELINIZATION; STEM CELL;

ANIMALS; ANTIGENS, CD; APOPTOSIS; B-LYMPHOCYTES; BRAIN CHEMISTRY; CORPUS CALLOSUM; CUPRIZONE; DEMYELINATING DISEASES; DISEASE MODELS, ANIMAL; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; MACROPHAGES; MALE; MICE; MICE, KNOCKOUT; MICROGLIA; MONOAMINE OXIDASE INHIBITORS; MYELIN SHEATH; OLIGODENDROGLIA; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; STEM CELLS; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 0035705454     PISSN: 10976256     EISSN: None     Source Type: Journal    
DOI: 10.1038/nn738     Document Type: Article

References (46)

1. Central nervous system demyelination and remyelination in the mouse: An ultrastructural study of cuprizone toxicity
2. Demyelination and remyelination in the rat central nervous system following ethidium bromide injection
3. Endogenous progenitors remyelinate demyelinated axons in the adult CNS
4. Proliferation of mature oligodendrocytes after trauma to the central nervous system
5. Embryonic expression of myelin genes: Evidence for a focal source of oligodendrocyte precursors in the ventricular zone of the neural tube
6. A crucial role for neurotrophin-3 in oligodendrocyte development
7. Origin of oligodendrocytes within the human spinal cord
8. Evidence for migration of oligodendrocyte-type-2 astrocyte progenitor cells into the developing rat optic nerve
9. Progenitor cells of the adult mouse subventricular zone proliferate, migrate and differentiate into oligodendrocytes after demyelination
10. Delayed changes in growth factor gene expression during slow remyelination in the CNS of aged rats
11. Mature oligodendrocyte apoptosis precedes IGF-I production and oligodendrocyte progenitor accumulation and differentiation during demyelination/remyelination
12. Cooperation of both TNF receptors in inducing apoptosis: Involvement of the TNF receptor-associated factor binding domain of the TNF receptor 75
13. Overexpression of the p80 TNF receptor leads to TNF-dependent apoptosis, nuclear factor-κ B activation, and c-Jun kinase activation
14. TNFR80-dependent enhancement of TNFR60-induced cell death is mediated by TNFR-associated factor 2 and is specific for TNFR60
15. Apoptosis control by death and decoy receptors
16. Cytokine regulation of secondary lymphoid organ development
17. The TNF and TNF receptor superfamilies: Integrating mammalian biology
18. Dual role of tumor necrosis factor α in brain injury
19. TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination
20. Uncoupling the proinflammatory from the immunosuppressive properties of tumor necrosis factor (TNF) at the p55 TNF receptor level. Implications for pathogenesis and therapy of autoimmune demyelination
21. TNF neutralization in MS: Results of a randomized, placebo-controlled multicenter study
22. Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2
23. The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system
24. Microglial/macrophage accumulation during cuprizone-induced demyelination in C57BL/6 mice
25. Gene expression in brain during cuprizone-induced demyelination and remyelination
26. Rapid upregulation of the Pi isoform of glutathione-S-transferase in mouse brains after withdrawal of the neurotoxicant, cuprizone
27. Myelination in the absence of galactocerebroside and sulfatide: Normal structure with abnormal function and regional instability
28. Monoclonal autoantibodies promote central nervous system repair in an animal model of multiple sclerosis
29. Identification of autoantibodies associated with myelin damage in multiple sclerosis
30. Role of lymphotoxin and the type I TNF receptor in the formation of germinal centers
31. Immune and inflammatory responses in TNFα-deficient mice: A critical requirement for TNF α in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response
32. Characterization of tumor necrosis factor-deficient mice
33. The role of oligodendrocytes and oligodendrocyte progenitors in CNS remyelination
34. Differential oligodendroglial expression of the tumor necrosis factor receptors in vivo and in vitro
35. Differential expression, cytokine modulation, and specific functions of type-1 and type-2 tumor necrosis factor receptors in rat glia
36. Multiple sclerosis: Expression of molecules of the tumor necrosis factor ligand and receptor families in relationship to the demyelinated plaque
37. Tumor necrosis factor-α modulates the proliferation of neural progenitors in the subventricular/ventricular zone of adult rat brain
38. An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis
39. Critical points of tumor necrosis factor action in central nervous system autoimmune inflammation defined by gene targeting
40. Gene therapy for chronic relapsing experimental allergic encephalomyelitis using cells expressing a novel soluble p75 dimeric TNF receptor
41. Oligodendrocyte apoptosis and primary demyelination induced by local TNF/p55TNF receptor signaling in the central nervous system of transgenic mice: Models for multiple sclerosis with primary oligodendrogliopathy
42. The induction of EAE is only partially dependent on TNF receptor signaling but requires the IL-1 type I receptor
43. Interleukin-1β promotes repair of the CNS
44. A pi form of glutathione-S-transferase is a myelin- and oligodendrocyte-associated enzyme in mouse brain
45. Interaction between NG2 proteoglycan and PDGF α-receptor on O2A progenitor cells is required for optimal response to PDGF